Skip to main content
Back to OrbiMed

OrbiMed's Therapeutics Portfolio

Browse 43 Therapeutics companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
43
Total Funding in Therapeutics
$3.6B

Therapeutics Portfolio Companies (43)

Export
BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

San Diego, United States
April 2026
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

MedicalTherapeutics

Leal Therapeutics develops novel therapeutics for patients.

Worcester, United States
August 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Watertown, United States
October 2024
$115.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedical DeviceTherapeutics

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

San Francisco, United States
January 2024
$40.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Paris, France
September 2023
$69.5M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareManufacturingTherapeutics

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

San Francisco, United States
December 2025
$70.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

San Diego, United States
December 2025
$84.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

San Francisco, United States
November 2025
$185.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

San Diego, United States
November 2025
$115.0M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

San Diego, United States
November 2025
$100.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Palo Alto, United States
January 2026
$200.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Cambridge, United States
October 2025
$155.3M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsPharmaceuticalTherapeutics

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Dallas, United States
September 2025
$29.4M
Debt Financing

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

New York, United States
September 2025
$17.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Boston, United States
July 2025
$175.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

San Diego, United States
May 2025
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Cambridge, United States
March 2025
$50.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

La Jolla, United States
December 2024
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

Rockville, United States
November 2024
$69.4M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Raleigh, United States
August 2024
$105.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Dover, United States
July 2024
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio